https://www.fxstreet.com/news/pharma-stocks-roar-back-following-trumps-90-day-tariff-pause-202504091940
US President Donald Trump’s sudden, shocking 90-day pause on his so-called “reciprocal” tariffs (they were not reciprocal) has helped pharmaceutical stocks recover on Wednesday. …
Pharma stocks roar back following Trump’s 90-day tariff pause
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Kraken Exchange to List Binance Coin $BNB on April 22 With Four Trading Pairs
- Ethereum Eyes Another Correction as Selloff Risks Grow: What’s Next for ETH Price?
- Andreessen Horowitz (A16Z) Acquires an Additional $55M of LayerZero (ZRO) Tokens
- XRP Beats Ethereum for 6 Months Straight – Will XRP Become Next Largest Altcoin?
- Chainlink (LINK) Price Prediction for April 17: Experts Insights and Analysis
- Forex Today: Japanese CPI data will take centre stage on Good Friday
- Pound Sterling Price News and Forecast: GBP/USD holds steady near 1.3250 after mixed US economic data
- Dow Jones crashes over 500 points as UnitedHealth tanks, Trump slams Powell for delayed cuts
- UnitedHealth stock caves 23% as it cuts full-year guidance
- GBP/USD holds steady near 1.3250 after mixed US economic data
More from UncategorizedMore posts in Uncategorized »
- ImmediateFastx: Simplified cryptocurrency trading tool
- Kraken Exchange to List Binance Coin $BNB on April 22 With Four Trading Pairs
- Ethereum Eyes Another Correction as Selloff Risks Grow: What’s Next for ETH Price?
- Andreessen Horowitz (A16Z) Acquires an Additional $55M of LayerZero (ZRO) Tokens
- XRP Beats Ethereum for 6 Months Straight – Will XRP Become Next Largest Altcoin?
- Chainlink (LINK) Price Prediction for April 17: Experts Insights and Analysis
- Forex Today: Japanese CPI data will take centre stage on Good Friday
- Pound Sterling Price News and Forecast: GBP/USD holds steady near 1.3250 after mixed US economic data
- Dow Jones crashes over 500 points as UnitedHealth tanks, Trump slams Powell for delayed cuts
- UnitedHealth stock caves 23% as it cuts full-year guidance
